These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 4566798)

  • 1. Problems of dialysis in transplant patients.
    Sadler JH
    Transplant Proc; 1972 Dec; 4(4):571-4. PubMed ID: 4566798
    [No Abstract]   [Full Text] [Related]  

  • 2. Secondary hyperparathyroidism in chronic renal failure. The clinical spectrum in uremia, during hemodialysis, and after renal transplantation.
    Massry SG; Coburn JW; Popovtzer MM; Shinaberger JH; Maxwell MH; Kleeman CR
    Arch Intern Med; 1969 Oct; 124(4):431-41. PubMed ID: 4901739
    [No Abstract]   [Full Text] [Related]  

  • 3. 1alpha(OH)D3 One-alpha-hydroxy-cholecalciferol--an active vitamin D analog. Clinical studies on prophylaxis and treatment of secondary hyperparathyroidism in uremic patients on chronic dialysis.
    Brandi L
    Dan Med Bull; 2008 Nov; 55(4):186-210. PubMed ID: 19232159
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Indications for parathyroidectomy in advanced renal disease.
    Buck BA; Robertson RD
    Surg Gynecol Obstet; 1971 Aug; 133(2):218-24. PubMed ID: 4935588
    [No Abstract]   [Full Text] [Related]  

  • 5. Effects of dialysis prescription on bone and mineral metabolism: the National Cooperative Dialysis Study.
    Harter HR; Laird NM; Teehan BP
    Kidney Int Suppl; 1983 Apr; (13):S73-9. PubMed ID: 6345900
    [No Abstract]   [Full Text] [Related]  

  • 6. [Cardiovascular complications in advanced uremia].
    Jacobs C; Aubert P; Legrain M
    Ann Cardiol Angeiol (Paris); 1973 Oct; 22(5):401-8. PubMed ID: 4589012
    [No Abstract]   [Full Text] [Related]  

  • 7. Hyperparathyroidism in chronic renal failure and dialysis osteodystrophy.
    O'Riordan JL; Page J; Kerr DN; Walls J; Moorhead J; Crockett RE; Franz H; Ritz E
    Q J Med; 1970 Jul; 39(155):359-76. PubMed ID: 5478506
    [No Abstract]   [Full Text] [Related]  

  • 8. Azotemic osteodystrophy - indications for intervention.
    Ritz E
    Prog Biochem Pharmacol; 1980; 17():251-8. PubMed ID: 7208504
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Treatment of chronic uremia in childhood. II. Hemodialysis.
    Potter D; Larsen D; Leumann E; Perin D; Simmons J; Piel CF; Holliday MA
    Pediatrics; 1970 Nov; 46(5):678-89. PubMed ID: 4921218
    [No Abstract]   [Full Text] [Related]  

  • 10. Plasma calcium fraction dynamics in uremic patients undergoing hemodialysis.
    Asad SN; Olmer AJ; Letteri JM
    Miner Electrolyte Metab; 1984; 10(5):333-6. PubMed ID: 6493162
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of calcium and phosphorus on patients maintained on dialysis.
    Goldsmith RS; Arnaud CD; Johnson WJ
    Kidney Int Suppl; 1975 Jan; (2):118-22. PubMed ID: 1099298
    [No Abstract]   [Full Text] [Related]  

  • 12. Secondary hyperparathyroidism in uraemic patients on chronic haemodialysis--a case report and review.
    Lim YK
    Singapore Med J; 1973 Jun; 14(2):99-103. PubMed ID: 4741441
    [No Abstract]   [Full Text] [Related]  

  • 13. Caclium, phosphorus, and bone in renal disease and transplantation.
    Bricker NS; Slatopolsky E; Reiss E; Avioli LV
    Arch Intern Med; 1969 May; 123(5):543-53. PubMed ID: 4888973
    [No Abstract]   [Full Text] [Related]  

  • 14. Secondary hyperparathyroidism in chronic renal failure.
    Malmaeus J
    Scand J Urol Nephrol Suppl; 1983; 70():1-63. PubMed ID: 6351238
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Parathyroid morphology in suppressible and nonsuppressible renal hyperparathyroidism.
    Black WC; Slatopolsky E; Elkan I; Hoffsten P
    Lab Invest; 1970 Nov; 23(5):497-509. PubMed ID: 5483883
    [No Abstract]   [Full Text] [Related]  

  • 16. Hypercalcemia with calcium carbonate for uraemic hyperparathyroidism: consequence of a challenge overmet by the nephrologist?
    Fournier A
    Nephrol Dial Transplant; 1993; 8(2):188-9. PubMed ID: 8384346
    [No Abstract]   [Full Text] [Related]  

  • 17. Round table discussion: divalent ion metabolism and osteodystrophy in chronic renal failure.
    Arch Intern Med; 1969 Dec; 124(6):670-82. PubMed ID: 4902870
    [No Abstract]   [Full Text] [Related]  

  • 18. The control of hyperphosphataemia in haemodialysis patients.
    Papayianni L; Katopodis K; Kosmanou J; Banioti A; Katsaraki A; Palatzidou M; Prokopiou F; Betsiou V; Siamopoulos KC
    EDTNA ERCA J; 1997; 23(4):25-7. PubMed ID: 9664020
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dialysis bone disease.
    Ritz E; Krempien B; Kuhn H; Heuck F
    Isr J Med Sci; 1971 Mar; 7(3):520. PubMed ID: 5567544
    [No Abstract]   [Full Text] [Related]  

  • 20. The treatment of metabolic bone disease in patients on peritoneal dialysis.
    Armstrong A; Cunningham J
    Kidney Int Suppl; 1994 Dec; 48():S51-7. PubMed ID: 7700042
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.